Home/Filings/4/0001670579-25-000008
4//SEC Filing

Haurwitz Rachel E. 4

Accession 0001670579-25-000008

CIK 0001619856other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 8:01 AM ET

Size

6.0 KB

Accession

0001670579-25-000008

Insider Transaction Report

Form 4
Period: 2025-03-14
Haurwitz Rachel E.
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2025-03-14$1.02/sh+20,000$20,4003,369,395 total(indirect: By Trust)
Holdings
  • Common Stock

    295,450
Footnotes (2)
  • [F1]This transaction was executed in multiple trades on 3/14/2025 at prices ranging from $1.00 to $1.03 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the specified range.
  • [F2]Shares are held by The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse.

Issuer

Caribou Biosciences, Inc.

CIK 0001619856

Entity typeother

Related Parties

1
  • filerCIK 0001670579

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 8:01 AM ET
Size
6.0 KB